RET (NM_020975) Human Tagged Lenti ORF Clone
CAT#: RC214268L1
- LentiORF®
Lenti-ORF clone of RET (Myc-DDK-tagged)-Human ret proto-oncogene (RET), transcript variant 2
"NM_020975" in other vectors (7)
Specifications
Product Data | |
Type | Human Tagged ORF Clone |
Tag | Myc-DDK |
Symbol | RET |
Synonyms | CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET-ELE1 |
Vector | pLenti-C-Myc-DDK |
E. coli Selection | Chloramphenicol (34 ug/mL) |
Mammalian Cell Selection | None |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC214268).
|
Restriction Sites | SgfI-MluI Cloning Scheme for this gene Plasmid Map |
ACCN | NM_020975 |
ORF Size | 3342 bp |
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Product Components | The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water). |
Reconstitution | 1. Centrifuge at 5,000xg for 5min. 2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA. 3. Close the tube and incubate for 10 minutes at room temperature. 4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom. 5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C. |
Reference Data | |
RefSeq | NM_020975.3 |
RefSeq Size | 5629 bp |
RefSeq ORF | 3345 bp |
Locus ID | 5979 |
UniProt ID | P07949 |
Cytogenetics | 10q11.21 |
Protein Families | Druggable Genome, Protein Kinase, Transmembrane |
Protein Pathways | Endocytosis, Pathways in cancer, Thyroid cancer |
MW | 124.3 kDa |
Gene Summary | This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
RC214268 | RET (Myc-DDK-tagged)-Human ret proto-oncogene (RET), transcript variant 2 |
USD 970.00 |
|
RC214268L2 | Lenti-ORF clone of RET (mGFP-tagged)-Human ret proto-oncogene (RET), transcript variant 2 |
USD 1,270.00 |
|
RC214268L3 | Lenti-ORF clone of RET (Myc-DDK-tagged)-Human ret proto-oncogene (RET), transcript variant 2 |
USD 1,270.00 |
|
RC214268L4 | Lenti-ORF clone of RET (mGFP-tagged)-Human ret proto-oncogene (RET), transcript variant 2 |
USD 1,270.00 |
|
RC600076 | RET (DDK-His-tagged)-Extra Cellular Domain Clone of Homo sapiens ret proto-oncogene, transcript variant 2, Signal peptide (1-28) plus EC domain (29-635) |
USD 591.00 |
|
RG214268 | RET (tGFP-tagged) - Human ret proto-oncogene (RET), transcript variant 2 |
USD 1,170.00 |
|
SC309554 | RET (untagged)-Human ret proto-oncogene (RET), transcript variant 2 |
USD 971.00 |
{0} Product Review(s)
Be the first one to submit a review